Feed Articles

7 interesting healthcare stocks for long-term investment

From pharmaceutical companies to biotech innovators, these companies are bringing modern and effective solutions to the healthcare industry, and companies in this sector are likely to be profitable for years to come.

At a time when the economy is subject to uncertainty, it is advisable to focus on sectors that can withstand market fluctuations. The healthcare sector appears to be stable and attractive for investment as people continue to place a premium on their overall health.

Illumina $ILMN

Illumina, a cutting-edge biotechnology company that manufactures and sells systems for the analysis of genetic and biological functions. Although the stock has shownvolatility over the past year, this market likely offers tremendous upside potential. With this market expected to grow to $83.1 billion by 2028, Illumina represents an exciting investment opportunity.

Hologic $HOLX

Hologic, a medical technologycompany focused on women's health, provides diagnostic and surgical solutions. With an expected global market growth to $34.6 billion by 2030, Hologic has the potential to see significant growth.

Johnson & Johnson $JNJ

Johnson & Johnson Focuses on pharmaceutical and medical technology. With a global medical device market worth $799 billion by 2030 and a pharmaceutical market reaching $2.8 trillion, JNJ remains one of the most important healthcare stocks.

Modern $MRNA

Moderna, known for its role in the development of the Covid-19 vaccine, is moving into new innovations. With the global cancer vaccine market projected to grow to $16.84 billion, Moderna may offer exciting investment opportunities.

Editas Medicine $EDIT

Editas Medicine, which deals with therapies for rare diseases using special technology, represents a riskier but innovative investment. Thus Editas Medicine may be attractive to investors with a higher appetite for risk.

Verve Therapeutics $VERV

Company Verve Therapeutics focuses on protecting against cardiovascular disease using "gene circuit" technology. With the global market expected to grow to $5.78 billion by 2030, VERV may represent a unique investment opportunity.

Intellia Therapeutics $NTLA

Company Intellia Therapeutics has become a pioneer in the field of gene therapy using revolutionary technologies. The company focuses on treating genetic diseases using special technologies. With the rapid development of this field and increasing awareness of the potential of gene therapy, Intellia Therapeutics offers an investment opportunity in an area with tremendous innovation potential.

Disclaimer: There is a lot of inspiration to be found on Bulios, however, stock selection and portfolio construction is entirely up to you, so always conduct thorough self-analysis.

Source.

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy